In models of autoimmune disease in animals and in spontaneous human autoimmune diseases, CD4+ T cells are pathophysiologically involved in disease initiation and progression. Irrespective of the target organ involved, it is likely that similar mechanisms underlie autoimmune disease predisposition and/or induction. One event that seems to be related to the induction of autoimmune disease is loss of """"""""immune regulation"""""""". This loss of immune regulation is thought to be a major mechanism underlying most autoimmune diseases. Two of the three projects described within the body of this application (Projects 1 and 2) are directed toward restoring immune regulation in animal models of autoimmune disease through specific immune reconstitution or deviation, or by activating dormant immunoregulatory features of natural regulatory pathways to """"""""prevent"""""""" disease initiation or progression. Studies described in Project 3 will use a novel technology of protein arrays screened with autoantibodies to assist in the selection of therapeutic products and as a potential surrogate to success. All three projects described in the body of this grant (as well as the two Innovative Projects) are connected with the overall goal of identifying and then """"""""preventing"""""""" induction or progression of the dysregulated autoimmune state. It is hypothesized that autoimmune diseases progress through several (at least two) """"""""checkpoints"""""""", an early inflammatory and late phase destructive disease. We believe it might be possible to design ways to identify the two phases and then to develop """"""""common prevention strategies"""""""" to arrest disease induction or progression in one or both of these phases. Strategies described in the application suggest that gene therapy or cDNA vaccination might prove effective in the prevention of autoimmune disease induction or perpetuation. If any of these strategies are successful, it is planned to progress to clinical trial application under future funding from this program.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19DK061934-05
Application #
6930558
Study Section
Special Emphasis Panel (ZAI1-PTM-I (S1))
Program Officer
Akolkar, Beena
Project Start
2001-09-29
Project End
2007-06-30
Budget Start
2005-07-01
Budget End
2007-06-30
Support Year
5
Fiscal Year
2005
Total Cost
$934,000
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Rosenberg, Jacob M; Price, Jordan V; Barcenas-Morales, Gabriela et al. (2016) Protein microarrays identify disease-specific anti-cytokine autoantibody profiles in the landscape of immunodeficiency. J Allergy Clin Immunol 137:204-213.e3
Teo, Pearline Zhaoying; Utz, Paul J; Mollick, Joseph A (2012) Using the allergic immune system to target cancer: activity of IgE antibodies specific for human CD20 and MUC1. Cancer Immunol Immunother 61:2295-309
Kattah, Nicole H; Kattah, Michael G; Utz, Paul J (2010) The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases. Immunol Rev 233:126-45
Graham, Kareem L; Lee, Lowen Y; Higgins, John P et al. (2010) Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice. Autoimmunity 43:140-55
Thibault, Donna L; Graham, Kareem L; Lee, Lowen Y et al. (2009) Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. Arthritis Res Ther 11:R112
Yip, Linda; Su, Leon; Sheng, Deqiao et al. (2009) Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes. Nat Immunol 10:1026-33
Kattah, Michael G; Coller, John; Cheung, Regina K et al. (2008) HIT: a versatile proteomics platform for multianalyte phenotyping of cytokines, intracellular proteins and surface molecules. Nat Med 14:1284-9
Drouvalakis, Katerina A; Bangsaruntip, Sarunya; Hueber, Wolfgang et al. (2008) Peptide-coated nanotube-based biosensor for the detection of disease-specific autoantibodies in human serum. Biosens Bioelectron 23:1413-21
Kodama, Keiichi; Butte, Atul J; Creusot, Remi J et al. (2008) Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice. Clin Immunol 129:195-201
Balboni, Imelda; Chan, Steven M; Kattah, Michael et al. (2006) Multiplexed protein array platforms for analysis of autoimmune diseases. Annu Rev Immunol 24:391-418

Showing the most recent 10 out of 48 publications